[go: up one dir, main page]

JPS55164622A - Manufacture of pancreatin pellet - Google Patents

Manufacture of pancreatin pellet

Info

Publication number
JPS55164622A
JPS55164622A JP7565880A JP7565880A JPS55164622A JP S55164622 A JPS55164622 A JP S55164622A JP 7565880 A JP7565880 A JP 7565880A JP 7565880 A JP7565880 A JP 7565880A JP S55164622 A JPS55164622 A JP S55164622A
Authority
JP
Japan
Prior art keywords
manufacture
pancreatin pellet
pancreatin
pellet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7565880A
Other languages
English (en)
Other versions
JPH0428691B2 (ja
Inventor
Buishiyuniefusukii Maruchin
Fuaihiyo Rutsu
Fuitsushiyaa Geruharuto
Petsushiyuke Giyuntaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6072800&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS55164622(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Publication of JPS55164622A publication Critical patent/JPS55164622A/ja
Publication of JPH0428691B2 publication Critical patent/JPH0428691B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
JP7565880A 1979-06-08 1980-06-06 Manufacture of pancreatin pellet Granted JPS55164622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2923279A DE2923279C2 (de) 1979-06-08 1979-06-08 Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JPS55164622A true JPS55164622A (en) 1980-12-22
JPH0428691B2 JPH0428691B2 (ja) 1992-05-15

Family

ID=6072800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7565880A Granted JPS55164622A (en) 1979-06-08 1980-06-06 Manufacture of pancreatin pellet

Country Status (22)

Country Link
US (1) US4280971A (ja)
EP (1) EP0021129B2 (ja)
JP (1) JPS55164622A (ja)
KR (1) KR850000625B1 (ja)
AR (1) AR228427A1 (ja)
AT (1) ATE6030T1 (ja)
AU (1) AU532838B2 (ja)
CA (1) CA1142082A (ja)
DD (1) DD151184A5 (ja)
DE (2) DE2923279C2 (ja)
DK (1) DK158932C (ja)
ES (1) ES489967A1 (ja)
FI (1) FI84022C (ja)
GR (1) GR69290B (ja)
IE (1) IE49584B1 (ja)
IL (1) IL59893A (ja)
NO (1) NO158949C (ja)
NZ (1) NZ193476A (ja)
PH (1) PH16898A (ja)
PT (1) PT71136A (ja)
SU (1) SU1256690A3 (ja)
ZA (1) ZA802919B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61170390A (ja) * 1985-01-25 1986-08-01 Agency Of Ind Science & Technol 酵素含有多糖複合体
JP2004513645A (ja) * 2000-11-15 2004-05-13 エウランド　インターナショナル　ソシエタ　ペル　アチオニ 高い安定性を有する膵臓酵素の極小球体とその製造方法

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
DE3642853A1 (de) * 1986-12-16 1988-06-23 Ulrich Von Dr Ing Pidoll Arzneimittel
IT1205716B (it) * 1987-01-21 1989-03-31 Samil Spa Procedimento per la preparazione di microsfere gastroresistenti ed enterosolubili di enzima digestivo e preparato faramceutico a microsfere cosi' prodotto
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
JP3025528B2 (ja) * 1989-11-24 2000-03-27 ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング パンクレアチン製剤
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5460812A (en) * 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
US5352682A (en) * 1993-03-08 1994-10-04 Digestive Care Inc. Compositions containing salts of bile acid-aminosalicylate conjugates
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
US5861291A (en) * 1997-02-24 1999-01-19 Biozymes Inc. Method for producing pancreatin which contains low amounts of residual organic solvent and product thereof
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
GB0012056D0 (en) * 2000-05-18 2000-07-12 Consejo Superior Investigacion Model for neurodegenerative disease
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
KR20020085376A (ko) * 2001-05-08 2002-11-16 (주) 인터코텍 화장품 조성물
US20030180279A1 (en) * 2002-03-19 2003-09-25 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
US20040197321A1 (en) * 2002-03-19 2004-10-07 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
BRPI0509148B8 (pt) 2004-03-22 2021-05-25 Abbott Products Gmbh composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina contendo tensoativos, seus usos e respectivos processos de fabricação
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
HUE034739T2 (en) * 2005-07-29 2018-02-28 Abbott Laboratories Gmbh Reduced viral pancreatin
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
EP1931316B2 (en) 2005-08-15 2017-02-22 Abbott Laboratories GmbH Controlled release pharmaceutical compositions for acid labile drugs
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
JP5966202B2 (ja) 2007-02-20 2016-08-10 アラガン ファーマシューティカルズ インターナショナル リミテッド 安定な消化酵素組成物
DE102007025858A1 (de) * 2007-06-01 2008-12-04 Grünenthal GmbH Verfahren zur Herstellung einer Arzneimitteldarreichungsform
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) * 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) * 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US20100021505A1 (en) * 2008-07-28 2010-01-28 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
NZ593831A (en) 2009-01-06 2013-09-27 Curelon Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
EP2947100B1 (en) 2009-01-06 2019-05-08 Galenagen, LLC Oral compositions for the treatment or the prevention of infections by E. Coli
BRPI0922653B8 (pt) 2009-01-29 2021-05-25 Nordmark Arzneimittel Gmbh & Co Kg uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
PL2295039T5 (pl) * 2009-08-28 2023-02-27 Nordmark Pharma Gmbh Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
BR112013007640A2 (pt) 2010-10-01 2017-09-26 Aptalis Pharma Ltd "composição, forma de dosagem, pacote, processo para a preparação da composição, processo para a preparação da forma de dosagem, método para tratamento ou prevenção de um distúrbio ou afecção associada a uma defeciência de enzima digestiva, método de terapia de substituição de enzima pacnreática e método para aperfeiçoar resultados nutricionais e de crescimento"
DE202011000728U1 (de) 2011-03-30 2011-06-09 Nordmark Arzneimittel GmbH & Co. KG, 25436 Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung
EP2701733B1 (en) 2011-04-21 2019-04-03 Curemark, LLC Compounds for the treatment of neuropsychiatric disorders
AU2012293325B2 (en) 2011-08-08 2015-05-07 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
KR20160087794A (ko) 2013-08-09 2016-07-22 앨러간 파마슈티컬스 인터내셔널 리미티드 장관 투여에 적합한 소화 효소 조성물
JP2017519490A (ja) 2014-06-19 2017-07-20 アプタリス ファルマ リミテッド 膵臓抽出物からのウイルス汚染の除去方法
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
WO2018191233A1 (en) 2017-04-10 2018-10-18 Curemark, Llc Compositions for treating addiction
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS523819A (en) * 1975-06-10 1977-01-12 Johnson & Johnson Entericccorted digestive enzyme composition and its preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3154603A (en) * 1961-08-02 1964-10-27 American Cyanamid Co Process for the preparation of spherical contact particles
DE1617363B1 (de) * 1967-12-06 1972-05-31 Boehringer & Soehne Gmbh Verfahren zur Herstellung hochaktiver Enzym-Verdauungspraeparate
USRE27214E (en) 1968-05-31 1971-11-02 Method and apparatus for making spherical granules
DE2035739A1 (en) * 1970-07-18 1972-01-27 Röhm FmbH, 6100 Darmstadt Oral enzyme prepsn - consisting of granulate with gastric juices-resistant coating in tablet or capsule form
GB1342409A (en) * 1970-07-23 1974-01-03 Ciba Geigy Ag Flowable pancreatin preparation of low microorgan ism content and a process for its manufacture
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
DE2512746C3 (de) * 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS523819A (en) * 1975-06-10 1977-01-12 Johnson & Johnson Entericccorted digestive enzyme composition and its preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61170390A (ja) * 1985-01-25 1986-08-01 Agency Of Ind Science & Technol 酵素含有多糖複合体
JP2004513645A (ja) * 2000-11-15 2004-05-13 エウランド　インターナショナル　ソシエタ　ペル　アチオニ 高い安定性を有する膵臓酵素の極小球体とその製造方法

Also Published As

Publication number Publication date
ZA802919B (en) 1981-05-27
PT71136A (en) 1980-05-01
US4280971A (en) 1981-07-28
FI84022B (fi) 1991-06-28
PH16898A (en) 1984-04-05
DK244480A (da) 1980-12-09
AR228427A1 (es) 1983-03-15
EP0021129A2 (de) 1981-01-07
NO158949C (no) 1988-11-16
EP0021129B2 (de) 1988-09-07
CA1142082A (en) 1983-03-01
SU1256690A3 (ru) 1986-09-07
KR830002513A (ko) 1983-05-30
KR850000625B1 (ko) 1985-05-06
IL59893A0 (en) 1980-06-30
AU532838B2 (en) 1983-10-13
DE2923279C2 (de) 1987-07-09
DE3066366D1 (en) 1984-03-08
DK158932C (da) 1991-01-21
DD151184A5 (de) 1981-10-08
FI84022C (fi) 1991-10-10
IL59893A (en) 1983-03-31
EP0021129B1 (de) 1984-02-01
ATE6030T1 (de) 1984-02-15
NO158949B (no) 1988-08-08
EP0021129A3 (en) 1981-11-11
IE800733L (en) 1980-12-08
NZ193476A (en) 1982-11-23
IE49584B1 (en) 1985-10-30
FI801779A7 (fi) 1980-12-09
DK158932B (da) 1990-08-06
ES489967A1 (es) 1980-10-01
NO801690L (no) 1980-12-09
AU5755280A (en) 1981-10-15
DE2923279B1 (de) 1980-11-20
JPH0428691B2 (ja) 1992-05-15
GR69290B (ja) 1982-05-13

Similar Documents

Publication Publication Date Title
JPS55164622A (en) Manufacture of pancreatin pellet
JPS5616486A (en) Manufacture of oxoalkylxanthine
JPS55106264A (en) Manufacture of benzimidazolylbenzofurans
JPS5653648A (en) Direct manufacture of betaamethylthiopropionealdehyde
JPS5612360A (en) Manufacture of oosubstituteddketoxime
JPS55154968A (en) Manufacture of epsilonncaprolactone
JPS55137115A (en) Manufacture of carboxyllatex
JPS55130966A (en) Manufacture of thiazolidinee22thione
JPS5625153A (en) Manufacture of methylenecycloamines
JPS55133361A (en) Manufacture of hydroxyethylazoles
JPS55105632A (en) Manufacture of etheralcohol
JPS55147285A (en) Novel manufacture of imidazobenzodiazepine
JPS5655375A (en) Manufacture of 11azolyll11phenoxyyalkanee22one
JPS55125156A (en) Manufacture of 11aminoo22phenoxyy44hydroxyyanthraquinone
JPS55111464A (en) Manufacture of 77acylindolinee22one
JPS5618990A (en) Manufacture of trialkoxysilanols
JPS5616419A (en) Manufacture of trifluoromethylnaphthalene
JPS55160770A (en) Manufacture of hexafluorotriarylisocyanurate
JPS55167295A (en) Improved manufacture of 3300demethylfortimicins
JPS5610177A (en) Manufacture of 22isopropylaminopyrimidine
JPS5620561A (en) Manufacture of benzylcyanides
JPS5632449A (en) Manufacture of naphthalenesulfonylchloride
JPS5612388A (en) Manufacture of pyrenzepin
JPS56123967A (en) Manufacture of omegaalactam
JPS55116690A (en) Manufacture of fertilizer pellet